Albemarle drops to $98.51 ahead of Q3 reporting with projected $2.44 EPS
Question
Albemarle drops to $98.51 ahead of Q3 reporting with projected $2.44 EPS
Direct answer
Specialty chemicals and lithium producer Albemarle shares fell 2.73% to close at $98.51, deepening a 30-day retreat that has reached 13.83%. Market consensus projects Q3 EPS of $2.44 against depressed prior-year comps, creating a key catalyst point given the stock's current negative rank.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-13
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Albemarle drops to $98.51 ahead of Q3 reporting with projected $2.44 EPS”, revision 1, evidence through 2026-10-13. https://marketontology.com/market-events/2026-10-13/albemarle-drops-to-98-51-ahead-of-q3-reporting-with-projected-2-44-eps-79fe71
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| ALB | lithium chemical pricing dynamics and Q3 earnings multiple adjustments | Mixed1-4w | Stock dropped to $98.51 with Q3 EPS modeled at $2.44 against a 13.83% monthly drop. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
Price follow-up pending — no stored daily closes for these assets yet.
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-10-17Albemarle drops to $95.39 as 1-month loss reaches 14.66% ahead of Nov. 4 reportALB LIT
- 2026-10-17Albemarle Falls 2.84% to $95.39 as Chemical Specialty Multiple Contracts Before Q3ALB
- 2026-10-17Albemarle drops to $95.39 as 1-month loss reaches 14.66% ahead of Nov. 4 reportALB LIT
- 2026-10-17Albemarle Falls 2.84% to $95.39 as Chemical Specialty Multiple Contracts Before Q3ALB
- 2026-10-13Albemarle Falls 2.73% to $98.51 Despite Forecasted Q3 EPS SurgeALB CPER-1.95%
- 2026-10-13Albemarle Extends Monthly Decline to 13.8% Amid Volatile Chemical Cycle ExpectationsALB LIT
- 2026-10-13Albemarle Falls 2.73% to $98.51 Despite Forecasted Q3 EPS SurgeALB
- 2026-10-13Albemarle Falls 13.8% in One Month as Rank Downgrade Tempers Q3 EPS OutlookALB SPY-1.08%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.